23andMe, the California-based lab that has clashed with the Food and Drug Administration over the molecular testing it has offered to the public, has recently raised $79 million from outside investors, according to a recent filing with the U.S. Securities and Exchange Commission. According to the July 2 filing, 23andMe said it is planning to…
23andMe Raises $79 Million From Undisclosed Investors
23andMe, the California-based lab that has clashed with the Food and Drug Administration over the molecular testing it has offered to the public, has recently raised $79 million from outside investors, according to a recent filing with the U.S. Securities and Exchange Commission. According to the July 2 filing, 23andMe said it is planning to […]